CLINICAL TRIALS PROFILE FOR PREVNAR 20
✉ Email this page to a colleague
All Clinical Trials for PREVNAR 20
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00227188 ↗ | Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. | Completed | Pfizer | 2003-05-01 | The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years) | |
NCT00323557 ↗ | Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients | Completed | Bayer | Phase 2 | 2004-06-01 | The goal of this clinical research study is to see if Leukine(R) (sargramostim) improves the effectiveness of the pneumococcal vaccine, a medicine used to prevent pneumococcal pneumonia, in patients with chronic lymphocytic leukemia (CLL). |
NCT00323557 ↗ | Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients | Completed | M.D. Anderson Cancer Center | Phase 2 | 2004-06-01 | The goal of this clinical research study is to see if Leukine(R) (sargramostim) improves the effectiveness of the pneumococcal vaccine, a medicine used to prevent pneumococcal pneumonia, in patients with chronic lymphocytic leukemia (CLL). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PREVNAR 20
Condition Name
Clinical Trial Locations for PREVNAR 20
Trials by Country
Clinical Trial Progress for PREVNAR 20
Clinical Trial Phase
Clinical Trial Sponsors for PREVNAR 20
Sponsor Name